Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucocorticoid Withdrawal and Glucocorticoid-induced Adrenal Insufficiency
NCT03153527Phase 4Recruiting
- Sponsor
- University Hospital Basel
- Start
- May 2017
- Primary completion
- Jun 2027
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
Phase 4, randomised, triple-blind trial of prednisone in autoimmune disease (2 arms), sponsored by University Hospital Basel. Primary endpoint: Time to any incidence at 6 months. Started May 2017; status: recruiting.
02
Drugs
prednisone
03
Conditions
autoimmune disease
Beyond the preview
Go deeper on NCT03153527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03153527.